Milestone Pharmaceuticals Inc

MIST

Company Profile

  • Business description

    Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

  • Contact

    1111 Dr. Frederik-Phillips Boulevard
    Suite 420
    MontrealQCH4M 2X6
    CAN

    T: +1 514 336-0444

    https://www.milestonepharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    38

Stocks News & Analysis

stocks

Reassuring organic growth for undervalued ASX share

Efficiency gains are starting to make their mark.
stocks

Big IPOs are enticing but are they good investments?

Historically, buzzy debuts have been painful for buyers.
stocks

This defensive ASX listed REIT offers a 5% yield

Solid outlook underpinned by rent uplifts and development pipeline.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,692.80143.80-1.63%
CAC 408,005.8174.93-0.93%
DAX 4025,131.57332.24-1.30%
Dow JONES (US)49,097.061,101.11-2.19%
FTSE 10010,406.8645.82-0.44%
HKSE22,410.80430.82-1.89%
NASDAQ23,879.20550.69-2.25%
Nikkei 22556,436.653,007.56-5.06%
NZX 50 Index14,107.41139.84-0.98%
S&P 5007,175.83147.80-2.02%
S&P/ASX 2008,592.60137.80-1.58%
SSE Composite Index3,533.7943.82-1.22%

Market Movers